Lasowski Juergen 4
4 · ONYX PHARMACEUTICALS INC · Filed May 16, 2013
Insider Transaction Report
Form 4
Lasowski Juergen
SVP, Corporate Development
Transactions
- Sale
Common Stock
2013-05-14$97.13/sh−1,194$115,979→ 32,083 total - Sale
Common Stock
2013-05-14$96.38/sh−2,988$287,988→ 33,277 total
Footnotes (2)
- [F1]The shares were sold at prices ranging from $95.0045 to $96.865. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The shares were sold at prices ranging from $97.01 to $97.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.